Difloxacin

Difloxacin

SCHEMBL148765

CN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

gyrAgyrB

The experimentally established mechanism targets of Difloxacin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 1.00
MEN1 O00255 2/20 1.00
KMT2A Q03164 2/20 1.00
KDM4E B2RXH2 9/20 0.76
ALDH1A1 P00352 8/20 0.76
HPGD P15428 4/20 0.76
HSD17B10 Q99714 4/20 0.76
DRD3 P35462 1/20 0.66
NPC1 O15118 1/20 0.61
GAA P10253 1/20 0.52
RAD52 P43351 1/20 0.52
BRD4 O60885 1/20 0.52
TSHR P16473 1/20 0.52
HTT P42858 1/20 0.52
CYP2J2 P51589 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
MAPT P10636 1/20 0.52
POLB P06746 1/20 0.51
HSP90AA1 P07900 1/20 0.51
RXFP1 Q9HBX9 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Difloxacin SCHEMBL29695838 1.00 LMNA (1.00) LMNAMEN1KMT2AKDM4EALDH1A1
Difloxacin SCHEMBL203110 0.99 LMNA (0.98) LMNAMEN1KMT2AKDM4EALDH1A1
Difloxacin SCHEMBL27973383 0.98 LMNA (0.96) LMNAMEN1KMT2AKDM4EALDH1A1
SCHEMBL9787515 0.93 LMNA (0.86) LMNAMEN1KMT2AKDM4EALDH1A1
SCHEMBL10531040 0.93 LMNA (0.86) LMNAMEN1KMT2AKDM4EALDH1A1
SCHEMBL9045162 0.92 LMNA (0.85) LMNAMEN1KMT2AKDM4EALDH1A1
SCHEMBL16518633 0.92 MEN1 (0.85) LMNAMEN1KMT2AKDM4EALDH1A1
SCHEMBL10861606 0.90 LMNA (0.82) LMNAMEN1KMT2AKDM4EALDH1A1
SCHEMBL11009907 0.90 MEN1 (0.81) LMNAMEN1KMT2AKDM4EALDH1A1
SCHEMBL10666385 0.90 LMNA (0.81) LMNAMEN1KMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4498 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12624057-B2 Bisphosphonate quinolone conjugates and uses thereof BIOVINC, LLC (US) 2026-05-12 US claimed
US-20260108619-A1 CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS HANGZHOU DAC BIOTECH CO., LTD. (CN) 2026-04-23 US claimed
US-12576124-B2 Formulation of a conjugate of a tubulysin analog to a cell-binding molecule HANGZHOU DAC BIOTECH CO., LTD (CN) 2026-03-17 US claimed
WO-2025264604-A1 SKIN CARE COMPOSITION AND METHOD OF USING THE SAME THE PROCTER & GAMBLE COMPANY (US) 2025-12-26 WO claimed
US-20250339551-A1 AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE DIFFERENT FUNCTIONAL SMALL MOLECULES FOR ENHANCED TREATMENT OF REFRACTORY DISEASES HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) 2025-11-06 US claimed
EP-4642492-A1 AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES Hangzhou Seehe Biotechnology Co., Ltd (CN) 2025-11-05 EP claimed
EP-4642484-A1 TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE Hangzhou Seehe Biotechnology Co., Ltd (CN) 2025-11-05 EP claimed
US-12350281-B2 Long-acting injectable formulations and use thereof DECHRA VETERINARY PRODUCTS, LLC (US) 2025-07-08 US claimed
EP-4571306-A1 STABILIZING OXYGEN IN A COMPOSITION Instrumentation Laboratory Company (US) 2025-06-18 EP claimed
CN-120142412-A Stabilizing oxygen in a composition 仪器实验室公司 2025-06-13 CN claimed
WO-1995020387-A1 METHOD FOR PREVENTING OR REDUCING PHOTOSENSITIVITY AND/OR PHOTOTOXICITY REACTIONS TO MEDICATIONS G.D. SEARLE & CO. (US) 1995-08-03 WO claimed
EP-0394553-B1 Use of fluorine containing pyridone carboxylic acid derivatives for preparing a medicament for the treatment of HIV infections DAIICHI SEIYAKU CO (JP) 1995-06-21 EP claimed
US-5284776-A Complexing with an iron salt and comparing the color to that of a known concentration; kits; veterinary medicine; adjusting the dosage in poultry drinking water ABBOTT LABORATORIES (US) 1994-02-08 US claimed
US-5223246-A Powdered mixture of antibacterial oxo-carboxylic acids having fused nitrogen rings, carbonates, water soluble binders, for treatment of drinking water for livestock TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-06-29 US claimed
EP-0470252-A1 ANTI-HIV DRUG DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1992-02-12 EP claimed
EP-0443381-A1 Effervescent composition, its production and use Takeda Chemical Industries, Ltd. (JP) 1991-08-28 EP claimed
WO-1991009616-A1 QUINOLONE ANTIBIOTICS ENCAPSULATED IN LIPID VESICLES YALE UNIVERSITY (US) 1991-07-11 WO claimed
EP-0394553-A2 Use of fluorine containing pyridone carboxylic acid derivatives for preparing a medicament for the treatment of HIV infections DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1990-10-31 EP claimed
WO-1990001933-A1 COMBINATION OF QUINOLONE ANTIBIOTICS AND STEROIDS FOR TOPICAL OPHTHALMIC USE ALCON LABORATORIES, INC. (US) 1990-03-08 WO claimed
US-4853225-A Process for implanting a medicament depot MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1989-08-01 US claimed